RecruitingNCT06917339
Patient and treatment factors linked to TMS outcomes
About this title
Read the official source — NCT06917339Observational studyAges 5–120United StatesDepression
Understand this study
Who could participate?
Listed age limits: 5 years to 120 years.
- Listed locations
- MalvernSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: February 25, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 156,000
- Sponsor
- Neuronetics
- Sponsor type
- Unknown or unclear
- Study type
- Observational
- Intervention type
- Device
- Locations
- United States
- Age range
- From 5 Years to 120 Years
- Official registry ID
- NCT06917339
- Official title
Show the full official title
Retrospective Analyses Evaluating the Real-World Effectiveness of NeuroStar® TMS and the Factors Associated With Clinical Outcomes
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Malvern
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Neuronetics.
Who can participate?
Listed age limits: 5 years to 120 years.
Is this study still recruiting?
The registry lists this study as recruiting.
